Diseases Market Research Reports

Medical Diseases Market Research Reports, Analysis & Trends

 
Publication Single User License (PDF) Price
PharmaSphere: Emerging Biotechnologies - Stem Cell Therapy

PharmaSphere: Emerging Biotechnologies - Stem Cell Therapy

Date Published: Nov 10 2014
PharmaSphere: Emerging Biotechnologies Stem Cell Therapy report provides strategic analysis of the global stem cells industry. It discusses key development trends, regulatory requirements in various markets, recent deals activity and industry dynamic trends, as well as describes the operations strategy of these companies.
$2,995.00
EpiCast Report: Celiac Disease - Epidemiology Forecast to 2023

EpiCast Report: Celiac Disease - Epidemiology Forecast to 2023

Date Published: Nov 10 2014
EpiCast Report: Celiac Disease - Epidemiology Forecast to 2023
 
$3,995.00
Interventional Cardiology (Devices & Technology) - Global Trends, Estimates and Forecasts, 2012-2018

Interventional Cardiology (Devices & Technology) - Global Trends, Estimates and Forecasts, 2012-2018

Date Published: Nov 3 2014
Global Interventional Cardiology market is estimated to reach US$22.2 billion by 2016. Global Interventional Cardiac Devices Industry market is worth US$20.6 billion by 2016, growing at a CAGR of 9.2% for the analysis period 2012-2018 respectively. North American region accounts for highest percentage approximately 35.8% (2015) of global share while Europe follows next with nearly 28.8% (2018) of the market. Asia-Pacific is the fastest growing region with a CAGR of 11.6% driving a market value of US$4.7 billion by 2015.
$4,450.00
Coronary Stents - Global Trends, Estimates and Forecasts, 2012-2018

Coronary Stents - Global Trends, Estimates and Forecasts, 2012-2018

Date Published: Nov 3 2014
Global Coronary Stents sector is projected to reach US$9.5 billion by 2016. The North America accounts for nearly 41% (2015) of the global value while Europe claims approximately 29% (2018). Asia-Pacific is the fastest growing region with a CAGR of 8.8% driving a market value of US$1.5 billion by 2015. On a global scale, projections for drug eluting stents market share indicate more than 55% by 2015 leaving the rest of the market to the bare metal stents and other devices.
$4,450.00
Coronary Stents - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018

Coronary Stents - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018

Date Published: Nov 3 2014
BRICSS Coronary Stents market value is expected to reach US$1 billion by 2016, primarily supported by the product types - Drug Eluting Stents, Bare Metal Stents, Absorbable Stents and …etc. China accounts for nearly 28% of the market share and India claims more than 23%. In terms of CAGR, India is the fastest growing region while China and South Korea are just behind. Among the product types, Drug Eluting Stents account more nearly half of the market value while Absorbable Stents segments indicate a close 14%.
$2,500.00
EpiCast Report: Type 1 Diabetes - Epidemiology Forecast to 2023

EpiCast Report: Type 1 Diabetes - Epidemiology Forecast to 2023

Date Published: Nov 1 2014
Type 1 diabetes is a type of diabetes that accounts for 10% of all diabetes cases. The condition occurs as a result of the autoimmune destruction of pancreatic beta cells, which are responsible for producing insulin - a hormone that regulates blood sugar. Type 1 diabetes, formerly referred to as insulin-dependent diabetes, mostly develops in children and young adults. Hence, it has also been called juvenile diabetes, although this term is no longer frequently used.
 
$3,995.00
Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2014

Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2014

Date Published: Oct 30 2014

Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2014

Summary

Global Markets Direct’s, ‘Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2014’, provides an overview of the Chronic Obstructive Pulmonary Disease (COPD)’s therapeutic pipeline.

$2,500.00
Atherosclerosis - Pipeline Review, H2 2014

Atherosclerosis - Pipeline Review, H2 2014

Date Published: Oct 30 2014

Atherosclerosis - Pipeline Review, H2 2014

Summary

Global Markets Direct’s, ‘Atherosclerosis - Pipeline Review, H2 2014’, provides an overview of the Atherosclerosis’s therapeutic pipeline.

$2,000.00
Spasticity - Pipeline Review, H2 2014

Spasticity - Pipeline Review, H2 2014

Date Published: Oct 30 2014

Spasticity - Pipeline Review, H2 2014

Summary

Global Markets Direct’s, ‘Spasticity - Pipeline Review, H2 2014’, provides an overview of the Spasticity’s therapeutic pipeline.

$2,000.00
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2014

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2014

Date Published: Oct 30 2014

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2014

Summary

Global Markets Direct’s, ‘Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2014’, provides an overview of the Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)’s therapeutic pipeline.

$2,000.00
Crohn's Disease - Pipeline Review, H2 2014

Crohn's Disease - Pipeline Review, H2 2014

Date Published: Oct 30 2014

Crohn's Disease - Pipeline Review, H2 2014

Summary

Global Markets Direct’s, ‘Crohn's Disease - Pipeline Review, H2 2014’, provides an overview of the Crohn's Disease’s therapeutic pipeline.

$2,000.00
Urinary Incontinence - Pipeline Review, H2 2014

Urinary Incontinence - Pipeline Review, H2 2014

Date Published: Oct 30 2014

Urinary Incontinence - Pipeline Review, H2 2014

Summary

Global Markets Direct’s, ‘Urinary Incontinence - Pipeline Review, H2 2014’, provides an overview of the Urinary Incontinence’s therapeutic pipeline.

$2,000.00
Neuropathic Pain - Pipeline Review, H2 2014

Neuropathic Pain - Pipeline Review, H2 2014

Date Published: Oct 30 2014

Neuropathic Pain - Pipeline Review, H2 2014

Summary

Global Markets Direct’s, ‘Neuropathic Pain - Pipeline Review, H2 2014’, provides an overview of the Neuropathic Pain’s therapeutic pipeline.

$2,000.00
Non-Hodgkin Lymphoma - Pipeline Review, H2 2014

Non-Hodgkin Lymphoma - Pipeline Review, H2 2014

Date Published: Oct 30 2014

Non-Hodgkin Lymphoma - Pipeline Review, H2 2014

Summary

Global Markets Direct’s, ‘Non-Hodgkin Lymphoma - Pipeline Review, H2 2014’, provides an overview of the Non-Hodgkin Lymphoma’s therapeutic pipeline.

$2,000.00
Chikungunya - Pipeline Review, H2 2014

Chikungunya - Pipeline Review, H2 2014

Date Published: Oct 30 2014

Chikungunya - Pipeline Review, H2 2014

Summary

Global Markets Direct’s, ‘Chikungunya - Pipeline Review, H2 2014’, provides an overview of the Chikungunya’s therapeutic pipeline.

$2,000.00
Colon Cancer - Pipeline Review, H2 2014

Colon Cancer - Pipeline Review, H2 2014

Date Published: Oct 30 2014

Colon Cancer - Pipeline Review, H2 2014

Summary

Global Markets Direct’s, ‘Colon Cancer - Pipeline Review, H2 2014’, provides an overview of the Colon Cancer’s therapeutic pipeline.

$2,000.00
Myocardial Ischemia - Pipeline Review, H2 2014

Myocardial Ischemia - Pipeline Review, H2 2014

Date Published: Oct 30 2014

Myocardial Ischemia - Pipeline Review, H2 2014

Summary

Global Markets Direct’s, ‘Myocardial Ischemia - Pipeline Review, H2 2014’, provides an overview of the Myocardial Ischemia’s therapeutic pipeline.

$2,000.00
Pituitary ACTH Hypersecretion (Cushing's Disease) - Pipeline Review, H2 2014

Pituitary ACTH Hypersecretion (Cushing's Disease) - Pipeline Review, H2 2014

Date Published: Oct 30 2014

Pituitary ACTH Hypersecretion (Cushing's Disease) - Pipeline Review, H2 2014

Summary

Global Markets Direct’s, ‘Pituitary ACTH Hypersecretion (Cushing's Disease) - Pipeline Review, H2 2014’, provides an overview of the Pituitary ACTH Hypersecretion (Cushing's Disease)’s therapeutic pipeline.

$2,000.00
Psoriasis - Pipeline Review, H2 2014

Psoriasis - Pipeline Review, H2 2014

Date Published: Oct 30 2014

Psoriasis - Pipeline Review, H2 2014

Summary

Global Markets Direct’s, ‘Psoriasis - Pipeline Review, H2 2014’, provides an overview of the Psoriasis’s therapeutic pipeline.

$2,000.00
Ulcerative Colitis - Pipeline Review, H2 2014

Ulcerative Colitis - Pipeline Review, H2 2014

Date Published: Oct 30 2014

Ulcerative Colitis - Pipeline Review, H2 2014

Summary

Global Markets Direct’s, ‘Ulcerative Colitis - Pipeline Review, H2 2014’, provides an overview of the Ulcerative Colitis’s therapeutic pipeline.

$2,000.00

Pages

Shopping cart

0 Items $0.00
Not able to find what you are looking for?
Call Us
WHY CHOOSE MARKET RESEARCH REPORTS?
1
Trusted By Leaders
2
Shop With Confidence
3
Customer Centric
4
Personalized Solutions
5
Secure Checkout

User login

Clients Who Trust Us

Orange, Google, Microsoft, Barclays, CassidianIntel, TPG, Elit Net, Cross Business Producers, AcmavolpakB. Braun, Cobham, fiserv, Harris, Wipro, AonAl Meera, Nomura Research Institute, Tata Consultancy Services, Amara Raja, Hiranandani EnergyMunich Re, Lotte Chemical, National Post, First Data